跳至主要内容
临床试验/ACTRN12619000956101
ACTRN12619000956101招募中未知

Reducing Morbidity and Mortality by Initiation of a novel In-Hospital Treatment for Patients with T2DM (REMIT-2-D).

Health Translation SA, South Australian Health and Medical Research institute0 个研究点目标入组 198 人开始时间: 2019年7月8日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
198

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Educational / counselling / training
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1.Non-Indigenous and Indigenous peoples of age 18 years and over.
  • 2.Patients with Type 2 Diabetes Mellitus with an underlying cardiac condition admitted to hospital

排除标准

  • 1.Non-Indigenous and Indigenous peoples under the age of 18 years.
  • 2.Women who are pregnant.
  • 3.Patients unable to give informed consent.

研究者

发起方
Health Translation SA, South Australian Health and Medical Research institute

相似试验

Improving self management of blood sugar control in... | 临床试验